Aldosterone makes human endothelium stiff and vulnerable

Kidney International

Volumn 67, Issue 5, 2005, Pages 1680-1682

  Oberleithner, Hans ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Atomic force microscopy; Cell stiffness; Endothelial compliance

Indexed keywords

ALDOSTERONE;

APICAL MEMBRANE; ATOMIC FORCE MICROSCOPY; CELL CULTURE; CONFERENCE PAPER; ENDOTHELIUM CELL; HUMAN; NANOTECHNOLOGY; PRIORITY JOURNAL; RIGIDITY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 17744390197     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00263.x     Document Type: Conference Paper

References (15)

1. STIER CT, JR., CHANDER PN, ROCHA R: Aldosterone as a mediator in cardiovascular injury. Cardiol Rev 10:97-107, 2002
2. HENDERSON RM, SCHNEIDER S, LI Q, et al: Imaging ROMK1 inwardly rectifying ATP-sensitive K+ channel protein using atomic force microscopy. Proc Natl Acad Sci USA 93:8756-8760, 1996
3. SCHNEIDER SW, MATZKE R, RADMACHER M, OBERLEITHNER H: Shape and volume of living aldosterone-sensitive cells imaged with the atomic force microscope. Methods Mol Biol 242:255-279, 2004
4. GOERGE T, NIEMEYER A, ROGGE P, et al: Secretion pores in human endothelial cells during acute hypoxia. J Membr Biol 187:203-211, 2002
5. HOH JH, SCHOENENBERGER C-A: Surface morphology and mechanical properties of MDCK monolayers by atomic force microscopy. J Cell Sci 107:1105-1114, 1994
6. OBERLEITHNER H, SCHNEIDER SW, HENDERSON RM: Structural activity of a cloned potassium channel (ROMK1) monitored with the atomic force microscope: The "molecular-sandwich" technique. Proc Natl Acad Sci USA 94:14144-14149, 1997
7. LOMBES M, OBLIN ME, GASC JM, et al: Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 71:503-510, 1992
8. OBERLEITHNER H, SCHNEIDER SW, ALBERMANN L, et al: Endothelial cell swelling by aldosterone. J Membr Biol 196:163-172, 2003
9. GOLESTANEH N, KLEIN C, VALAMANESH F, et al: Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 280:1300-1306, 2001
10. OBERLEITHNER H, LUDWIG T, RIETHMULLER C, et al: Human endothelium: target for aldosterone. Hypertension 43:952-956, 2004
11. KRUG AW, GROSSMANN C, SCHUSTER C, et al: Aldosterone stimulates epidermal growth factor receptor expression. J Biol Chem 278:43060-43066, 2003
12. DAI J, SHEETZ MP: Membrane tether formation from blebbing cells. Biophys J 77:3363-3370, 1999
13. RAJAGOPALAN S, DUQUAINE D, KING S, et al: Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation 105:2212-2216, 2002
14. FARQUHARSON CA, STRUTHERS AD: Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 101:594-597, 2000
15. FRITSCH NM, SCHIFFRIN EL: Aldosterone: a risk factor for vascular disease. Curr Hypertens Rep 5:59-65, 2003